Dose Table
See Sialanar’s® dosing table in full.
This content is intended for UK & ROI healthcare professionals. Not a healthcare professional? Return to audience selector.
Sialanar® is licensed for the symptomatic treatment of severe sialorrhoea in children and adolescents aged 3 years and older with chronic neurological disorders.1
Patients should start titration from dose level 1, increasing every 7 days until efficacy is balanced with undesirable effects1
Dose titrations should be conducted in discussion with the carer to assess both efficacy and undesirable effects until an acceptable maintenance dose is achieved.
Dose level should be titrated up until drooling is appropriately managed but reduced in the event of a known anticholinergic reaction.
Sialanar® should be administered three times per day:
The oral syringe should be gently washed with warm water and allowed to dry after each use (i.e. three times per day). Do not use a dishwasher 4
If your child is given the medicine through a feeding tube, flush the tube with 10 ml of water after you have given the medicine. 4
See Sialanar’s® dosing table in full.
Guidance on switching patients from hyoscine or 1mg/5ml glycopyrronium bromide oral solutions to Sialanar®.
Head to this section for guidance on side effects and titration. Safety
UK-SIA-25-0063 | October 2025
Adverse Event Reporting Information
UK: Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard.
Republic of Ireland: Adverse events should be reported. Reporting forms and information can be found at: www.hpra.ie.
Adverse events should also be reported to Proveca Limited. Phone: +44 333 200 1866 E-Mail: medinfo@proveca.com